- Home
- PRTA vs OOMA Comparison
PRTA vs OOMA Comparison
Compare PRTA & OOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- OOMA
- Stock Information
- Founded
- PRTA 2012
- OOMA 2003
- Country
- PRTA Ireland
- OOMA United States
- Employees
- PRTA N/A
- OOMA N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- OOMA EDP Services
- Sector
- PRTA Health Care
- OOMA Technology
- Exchange
- PRTA Nasdaq
- OOMA Nasdaq
- Market Cap
- PRTA 366.6M
- OOMA 379.7M
- IPO Year
- PRTA N/A
- OOMA 2015
- Fundamental
- Price
- PRTA $7.69
- OOMA $11.07
- Analyst Decision
- PRTA Buy
- OOMA Buy
- Analyst Count
- PRTA 10
- OOMA 6
- Target Price
- PRTA $24.29
- OOMA $17.63
- AVG Volume (30 Days)
- PRTA 955.8K
- OOMA 146.9K
- Earning Date
- PRTA 08-04-2025
- OOMA 08-26-2025
- Dividend Yield
- PRTA N/A
- OOMA N/A
- EPS Growth
- PRTA N/A
- OOMA N/A
- EPS
- PRTA N/A
- OOMA N/A
- Revenue
- PRTA $10,341,000.00
- OOMA $259,382,000.00
- Revenue This Year
- PRTA N/A
- OOMA $6.33
- Revenue Next Year
- PRTA $122.46
- OOMA $6.15
- P/E Ratio
- PRTA N/A
- OOMA N/A
- Revenue Growth
- PRTA N/A
- OOMA 7.01
- 52 Week Low
- PRTA $4.32
- OOMA $7.83
- 52 Week High
- PRTA $23.66
- OOMA $17.00
- Technical
- Relative Strength Index (RSI)
- PRTA 70.62
- OOMA 33.63
- Support Level
- PRTA $6.61
- OOMA $10.95
- Resistance Level
- PRTA $8.01
- OOMA $11.50
- Average True Range (ATR)
- PRTA 0.40
- OOMA 0.32
- MACD
- PRTA 0.10
- OOMA -0.05
- Stochastic Oscillator
- PRTA 81.40
- OOMA 8.28
About PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.
About OOMA Ooma Inc.
Ooma Inc is a communications services company. It is a smart software-as-a-service ("SaaS") and unified communications platform that deliver voice and collaboration features including messaging, intelligent virtual attendants and video conferencing, and residential phone service provides PureVoice high-definition voice quality, advanced functionality and integration with mobile devices. Its services rely upon the following main elements: multi-tenant cloud service, on-premise devices, desktop and mobile applications, and calling platforms. Ooma generates revenues from the sale of subscriptions and other services.